ELEleni Liapi

Eleni Liapi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eleni Liapi has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Human mascRNA interacts with SUMO E1 and reshapes nuclear SUMOylation

    by Eleni Liapi, Kaili Dawn Taylor, Aleah Marissa Holts, Joëlle Rudinger-Thirion, Claude Sauter, Anastasios Vourekas

    Human mascRNA is a tRNA-like 58-nucleotide non-coding RNA processed from the 3′ end of the MALAT1 transcript. Although mascRNA has been implicated in diverse cellular processes, its molecular mechanism has remained unclear. Here, we reveal a direct functional link between mascRNA and the SUMOylation pathway. Structural probing and SEC-SAXS confirm the compact, tRNA-like architecture of mascRNA in solution, while biochemical assays demonstrate its direct interaction with the SUMO E1 activating enzyme in vitro . Proteomic analyses show that mascRNA engages nuclear protein networks enriched for SUMOylated factors, including chromatin remodelers and nucleolar components. Transfection of synthetic mascRNA alters SAE2 and SUMO1 nuclear organization and broadly reduces nuclear SUMOylation, accompanied by decreased ProMyeLocytic (PML) body abundance and SUMO colocalization. SUMO1 immunoprecipitation and mass spectrometry reveal widespread decreases in SUMO conjugation, particularly among proteins involved in RNA metabolism and rRNA biogenesis with nuclear body localization. We further validate reduced SUMOylation of nucleolar factors such as BEND3 and ZNF106. These findings position mascRNA as a structured RNA ligand that modulates SUMO-dependent nuclear architecture and protein homeostasis, uncovering an unexpected intersection between RNA biology and post-translational modification networks. GRAPHICAL

  • Open Access

    Human skin long noncoding RNA WAKMAR1 regulates wound healing by enhancing keratinocyte migration

    by Dongqing Li, Lara Kular, Manika Vij, Eva K. Herter, Xi Li, Aoxue Wang, Tongbin Chu, Maria-Alexandra Toma, Letian Zhang, Eleni Liapi, et al.

    An increasing number of studies reveal the importance of long noncoding RNAs (lncRNAs) in gene expression control underlying many physiological and pathological processes. However, their role in skin wound healing remains poorly understood. Our study focused on a skin-specific lncRNA, LOC105372576, whose expression was increased during physiological wound healing. In human nonhealing wounds, however, its level was significantly lower compared with normal wounds under reepithelialization. We characterized LOC105372576 as a nuclear-localized, RNAPII-transcribed, and polyadenylated lncRNA. In keratinocytes, its expression was induced by TGF-β signaling. Knockdown of LOC105372576 and activation of its endogenous transcription, respectively, reduced and increased the motility of keratinocytes and reepithelialization of human ex vivo skin wounds. Therefore, LOC105372576 was termed “wound and keratinocyte migration-associated lncRNA 1” (WAKMAR1). Further study revealed that WAKMAR1 regulated a network of protein-coding genes important for cell migration, most of which were under the control of transcription factor E2F1. Mechanistically, WAKMAR1 enhanced E2F1 expression by interfering with E2F1 promoter methylation through the sequestration of DNA methyltransferases. Collectively, we have identified a lncRNA important for keratinocyte migration, whose deficiency may be involved in the pathogenesis of chronic wounds.


  • Open Access

    Identification of novel non‐coding RNA‐based negative feedback regulating the expression of the oncogenic transcription factor GLI1

    by Victoria E. Villegas, Mohammed Ferdous-Ur Rahman, Maite G. Fernandez-Barrena, Yumei Diao, Eleni Liapi, Enikö Sonkoly, Mona Ståhle, Andor Pivarcsi, Laura Annaratone, Anna Sapino, et al.

    Non‐coding RNAs are a complex class of nucleic acids, with growing evidence supporting regulatory roles in gene expression. Here we identify a non‐coding RNA located head‐to‐head with the gene encoding the Glioma‐associated oncogene 1 (GLI1), a transcriptional effector of multiple cancer‐associated signaling pathways. The expression of this three‐exon GLI1 antisense (GLI1AS) RNA in cancer cells was concordant with GLI1 levels. siRNAs knockdown of GLI1AS up‐regulated GLI1 and increased cellular proliferation and tumor growth in a xenograft model system. Conversely, GLI1AS overexpression decreased the levels of GLI1, its target genes PTCH1 and PTCH2, and cellular proliferation. Additionally, we demonstrate that GLI1 knockdown reduced GLI1AS, while GLI1 overexpression increased GLI1AS, supporting the role of GLI1AS as a target gene of the GLI1 transcription factor. Activation of TGFβ and Hedgehog signaling, two known regulators of GLI1 expression, conferred a concordant up‐regulation of GLI1 and GLI1AS in cancer cells. Finally, analysis of the mechanism underlying the interplay between GLI1 and GLI1AS indicates that the non‐coding RNA elicits a local alteration of chromatin structure by increasing the silencing mark H3K27me3 and decreasing the recruitment of RNA polymerase II to this locus. Taken together, the data demonstrate the existence of a novel non‐coding RNA‐based negative feedback loop controlling GLI1 levels, thus expanding the repertoire of mechanisms regulating the expression of this oncogenic transcription factor.